This MRes Cancer Biology course will give you advanced knowledge of cellular systems. You will learn about the pathogenesis of cancer, cardiovascular disease, diabetes and kidney fibrosis, along with an exploration of current approaches to cancer gene therapy and immunotherapy.
Visit us on campus throughout the year, find and register for our next open event on http://www.ntu.ac.uk/pgevents.
Help improve human or animal health through creating new or more effective drugs and medicines. Learn the research processes used to identify drug targets and develop new therapeutics.
Your studies will combine the biological sciences with chemistry, giving you the skills to target, design, synthesise, create and assess new drugs. You'll also learn about protecting intellectual property, assessing the financial viability of drugs and the pre-clinical and clinical trial processes.
Tailor your studies to your strengths, interests and career goals. You'll learn a mix of academic and practical skills that are closely aligned to the needs of industry.
The Master of Drug Discovery and Development is best suited to very able students with backgrounds in chemistry or relevant life-science subjects such as biochemistry, biomedical science, pharmacy or pharmacology. It is an intensive one-year taught programme, unique in New Zealand.
Learn from academics and professionals who are leaders in the field and have experience in successfully taking drugs to market. Each course is taught by at least three academics so you'll be exposed to a wide range of expertise.
Drug Discovery and Development is taught by the Schools of Chemical and Physical Sciences and Biological Sciences in collaboration with the University's Ferrier Research Institute and the Centre for Biodiscovery.
You'll be able to take advantage of the research expertise of the Ferrier Research Institute in drug design and development, and if you're doing a Master's, you'll be working alongside the more than 30 scientists who make up the largest carbohydrate research team in the world. The Institute also has its own manufacturing facility so you'll have the opportunity to observe the drug development process from discovery to product.
You'll also benefit from the programme's links with the Centre for Biodiscovery where you will interact with the research teams that are actively discovering, designing and assessing novel bioactive compounds.
Get wise to the real-world issues facing pharmaceutical development and make the most of the hard-earned experiences of staff who have worked in the local and international biotech industry. Learn not only how to handle chemicals on a large scale, but to develop the mindset to do this in a way that is safe, reliable and robust—so you end up providing medicines that will change people’s lives.
Victoria offers three postgraduate qualifications in Drug Discovery and Development. Choose the one that suits your career goals, time constraints and financial situation.
If you begin by enrolling in the Certificate or Diploma programme you can continue on to complete your Master's. Or if you enrol in the Master's but can't complete it, for whatever reason, you may have completed enough points to be awarded a Certificate or Diploma.
Each qualification includes the core courses DRGD 401 Chemical Biology and Drug Discovery, and a choice between DRDG 402 Drug Design or CHEM 421 Organic Chemistry and Bio-organic Chemistry.
After that you'll choose from selected courses from the study areas of Drug Discovery and Development, Biomedical Science, Biotechnology, Chemistry, Clinical Research and Microbiology.
All three qualifications give you the opportunity to do at least some research.
You'll complete four courses worth 60 points made up of the two core courses and two further choices.
You're likely to take seven courses that will include the two core courses, your elective options and the 30-point Research Preparation course.
You'll study for your Master's in two parts over three trimesters. In Part 1, the first two trimesters, you're likely to take seven courses that will include the core courses and a 30-point Research Preparation course.
In Part 2, you'll complete a full research project. Choose between DRDG 561 Applied Research Project, where you'll complete one or more problem-solving projects, or DRGD 590 Research Project, where you'll focus on medicinal chemistry and the formulation of active pharmaceutical products. In some cases you may be able to replace the research project with the thesis course DRGD 595.
Your Master's may be endorsed with a specialisation in either Drug Discovery, Drug Development or Chemical Biology. Check the requirements to find out what you need to do for these.
You can expect a workload of 40–45 hours a week for much of your studies.
The MDDD can be completed in 12 months full time, or in two years of part-time study but you'll need to discuss this option with the programme directorfirst. The Diploma will take you two trimesters and the Certificate one trimester.
You'll study at Wellington's Kelburn campus where you will have access to state-of-the-art research facilities. Students doing a research programme will also work in partnership the world-renowned Ferrier Research Institute in Lower Hutt.
Be part of a dynamic and collaborative scientific research community. Past students' research areas in drug discovery and development have included:
Become part of an active community of scientists. Postgraduate study at Victoria will help you build valuable relationships and networks with peers, university staff and future colleagues. You'll have unprecedented access to world industry leaders who visit as guest lecturers and run seminars with students.
You'll have the broad skills you need to work in drug discovery in companies, universities, research institutes or with drug regulatory authorities. You might work within the pharmaceutical, bioanalytical or chemical industries, or take your skills into nutraceuticals or agrichemicals.
Immunology is linked to our ability to remain healthy and free of disease - fighting off infections and disease and understanding our genetic factors and risk factors in inheriting disease. You look at behavioural factors and their links to disease to understand protection methods and you go into the detail of bioinformatics and genomics to understand DNA and analyse within practical research when you test for specific issues such as stress, hunger and so on and responses in the body.
The programme is designed for you to develop your academic knowledge of immunology and its relevance to disease with analysis and research skills designed to enhance your career prospects, or continue to PhD. You can use your training within educational establishments to apply training, work in patents, science outreach and public engagement.
Focusing on the relevance of the immune response in the maintenance of health and development of disease, graduates will be able to attain the intellectual and practical skills needed to address both theoretical and technical aspects of modern biomedical research.
In common with the other molecular biosciences Masters courses, the MSc in Immunology & Immunotherapy builds on recent advances in genomics to understand the generation of immunological diversity at a cellular level, how this imparts variability in immune responses at the individual and population level and the relevance of the immune system in disease areas such as autoimmunity, cancer, allergy and microbial infections.
You may also be interested in the Scottish Innovation Centres research and enterprise work with companies in Scotland to find out more about the possibilities in this area of health science and spin-out research going on from Aberdeen and other universities:
Find out more detail by visiting the programme web page
Find out about fees:
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
Find out more about:
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.